Cinemark (CNK) Q3 2026 earnings summary

Executive summary

• Q3 revenue was a third-quarter record of $1,059.1M, up 23.5% YoY; it was the second-highest quarter in history.

• Adjusted EBITDA reached a third-quarter record of $267.6M, with margin up 460 bps YoY to 25.3%.

• Attendance reached 63.7M; market-share gains since the pandemic exceeded 150 bps in both the U.S. and Latin America.

Financial highlights

• Q3 admissions revenue was $530.8M, concessions $413.9M and other revenue $114.4M; global admissions and concession revenue both set third-quarter records.

• Q3 operating income was $206.6M versus $114.4M; diluted EPS was $1.04 versus $0.40.

• Nine-month revenue rose 19.2% to $2,788.6M; net income attributable to shareholders was $255.8M versus $104.1M, and diluted EPS was $2.17 versus $0.77.

• Nine-month Adjusted EBITDA was $650.1M versus $446.2M; operating cash flow was $475.8M versus $248.3M.

Outlook and guidance

• FY2026 capital expenditures are expected to reach ~$250M; 9M investment was $169.7M across theater upgrades and new builds.

• Domestic concession per cap grew 5.5% year to date; management expects mid-single-digit growth for FY2026.

• Modest ATP growth is expected in FY2026 and remains a reasonable 2027 assumption; Q4 growth may moderate against the prior-year Avatar 3D comparison.

• 2027 film volume is pacing ahead of 2026 and could exceed pre-pandemic levels, with releases currently spread more evenly across the year.

• Management expects a few new builds annually in the near term; development timelines are longer than historically.